Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (4): 370-373.DOI: 10.3969/j.issn.1673-8640.2018.04.021
• Orginal Article • Previous Articles Next Articles
WANG Zhengyin, YIN Yuan, WANG Weiling
Received:
2017-03-18
Online:
2018-04-30
Published:
2018-04-26
CLC Number:
WANG Zhengyin, YIN Yuan, WANG Weiling. Research progress in the methods for creatinine determination and the interference of common drugs on creatinine determination[J]. Laboratory Medicine, 2018, 33(4): 370-373.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.04.021
药物种类 | 药物名称 | 检测方法 | 干扰方向 | 干扰浓度 | 文献 |
---|---|---|---|---|---|
抗菌药物类 | 头孢替坦二钠 | 苦味酸法 | 正干扰 | … | [13] |
注射用头孢西丁钠 | 苦味酸法 | 正干扰 | … | [13] | |
硫酸卡那霉素 | 苦味酸法 | 正干扰 | … | [13] | |
链霉素 | 苦味酸法 | 正干扰 | ≥10 mg/mL | [14] | |
甲氧苄啶 | 苦味酸法 | 正干扰 | … | [13] | |
利福平 | 酶法 | 负干扰 | ≥6.79 mmol/L | [15] | |
血管保护剂类 | 羟苯磺酸钙 | 酶法 | 负干扰 | ≥8 μg/mL | [16] |
注射用磷酸肌酸钠 | 酶法 | 负干扰 | … | [13] | |
镇痛消炎类 | 阿司匹林 | 苦味酸法 | 正干扰 | ≥0.33 mmol/L | [2] |
对乙酰氨基酚 | 苦味酸法 | 正干扰 | ≥40 μmol/L | [2] | |
安乃近 | 苦味酸法 | 正干扰 | ≥15 μmol/L | [2] | |
安乃近 | 酶法 | 负干扰 | ≥60 μmol/L | [2] | |
拟肾上腺类 | 盐酸多巴酚丁胺 | 酶法 | 负干扰 | ≥1.57 μg/mL | [17] |
多巴胺 | 酶法 | 负干扰 | ≥6.5×105pg/mL | [18-19] | |
维生素类 | 维生素C | 酶法 | 负干扰 | ≥0.3 g/L | [20] |
羟钴胺 | 苦味酸法 | 负干扰 | ≥15 mg/L | [21-22] | |
止血类 | 酚磺乙胺 | 酶法 | 负干扰 | ≥0.03 g/L | [23] |
解毒类 | 美司钠 | 苦味酸法 | 负干扰 | … | [13] |
N-乙酰半胱氨酸 | 酶法 | 负干扰 | ≥790 mg/L | [24] | |
噻唑烷二酮类 | 马来酸罗格列酮 | 苦味酸法 | 正干扰 | … | [25] |
抗肿瘤药物类 | 脂质体阿霉素 | 苦味酸法 | 负干扰 | ≥8 μg/mL | [26] |
中药注射剂类 | 双黄连注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] |
茵栀黄注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
香丹注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
脉络宁注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
痰热清注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
复方丹参注射液 | 酶法 | 负干扰 | ≥3.28 mL/L | [28] | |
灯盏花素注射液 | 酶法 | 负干扰 | ≥0.5 mg/mL | [29-30] | |
丹红注射液 | 酶法 | 负干扰 | ≥50 μL/mL | [31] | |
红花注射液 | 酶法 | 负干扰 | ≥40 mL/L | [32] |
药物种类 | 药物名称 | 检测方法 | 干扰方向 | 干扰浓度 | 文献 |
---|---|---|---|---|---|
抗菌药物类 | 头孢替坦二钠 | 苦味酸法 | 正干扰 | … | [13] |
注射用头孢西丁钠 | 苦味酸法 | 正干扰 | … | [13] | |
硫酸卡那霉素 | 苦味酸法 | 正干扰 | … | [13] | |
链霉素 | 苦味酸法 | 正干扰 | ≥10 mg/mL | [14] | |
甲氧苄啶 | 苦味酸法 | 正干扰 | … | [13] | |
利福平 | 酶法 | 负干扰 | ≥6.79 mmol/L | [15] | |
血管保护剂类 | 羟苯磺酸钙 | 酶法 | 负干扰 | ≥8 μg/mL | [16] |
注射用磷酸肌酸钠 | 酶法 | 负干扰 | … | [13] | |
镇痛消炎类 | 阿司匹林 | 苦味酸法 | 正干扰 | ≥0.33 mmol/L | [2] |
对乙酰氨基酚 | 苦味酸法 | 正干扰 | ≥40 μmol/L | [2] | |
安乃近 | 苦味酸法 | 正干扰 | ≥15 μmol/L | [2] | |
安乃近 | 酶法 | 负干扰 | ≥60 μmol/L | [2] | |
拟肾上腺类 | 盐酸多巴酚丁胺 | 酶法 | 负干扰 | ≥1.57 μg/mL | [17] |
多巴胺 | 酶法 | 负干扰 | ≥6.5×105pg/mL | [18-19] | |
维生素类 | 维生素C | 酶法 | 负干扰 | ≥0.3 g/L | [20] |
羟钴胺 | 苦味酸法 | 负干扰 | ≥15 mg/L | [21-22] | |
止血类 | 酚磺乙胺 | 酶法 | 负干扰 | ≥0.03 g/L | [23] |
解毒类 | 美司钠 | 苦味酸法 | 负干扰 | … | [13] |
N-乙酰半胱氨酸 | 酶法 | 负干扰 | ≥790 mg/L | [24] | |
噻唑烷二酮类 | 马来酸罗格列酮 | 苦味酸法 | 正干扰 | … | [25] |
抗肿瘤药物类 | 脂质体阿霉素 | 苦味酸法 | 负干扰 | ≥8 μg/mL | [26] |
中药注射剂类 | 双黄连注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] |
茵栀黄注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
香丹注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
脉络宁注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
痰热清注射液 | 苦味酸法 | 正干扰 | ≥1/10原液浓度 | [27] | |
复方丹参注射液 | 酶法 | 负干扰 | ≥3.28 mL/L | [28] | |
灯盏花素注射液 | 酶法 | 负干扰 | ≥0.5 mg/mL | [29-30] | |
丹红注射液 | 酶法 | 负干扰 | ≥50 μL/mL | [31] | |
红花注射液 | 酶法 | 负干扰 | ≥40 mL/L | [32] |
[1] | NAH H,LEE S G,LEE K S,et al.Evaluation of bilirubin interference and accuracy of six creatinine assays compared with isotope dilution-liquid chromatography mass spectrometry[J]. Clin Biochem,2016,49(3):274-281. |
[2] | LUNA-ZÁIZAR H,VIGREN-MONTELONGO M,CORTEZ-ÁLVAREZ C R,et al. In vitro interference by acetaminophen,aspirin,and metamizole in serum measurements of glucose,urea,and creatinine[J]. Clin Biochem,2015,48(7-8):538-541. |
[3] | JAFFÉ M:Über den Niederschlag welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaktion des Kreatinins[J]. Physiol Chem,1886,10(5):391-400. |
[4] | GREENBERG N,ROBERTS W L,BACHMANN L M,et al.Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles[J]. Clin Chem,2012,58(2):391-401. |
[5] | SAMRA M,ABCAR A C.False estimates of elevated creatinine[J]. Perm J,2012,16(2):51-52. |
[6] | 杨雪,王薇,张传宝,等. 我国肌酐检测系统性能分析[J]. 检验医学,2012,27(12):989-994. |
[7] | 黄霞梅,伍惠玲,钟慧芝,等. 肌氨酸氧化酶法和碱性苦味酸速率法检测血清肌酐结果比较和偏倚评估[J]. 重庆医学,2011,40(33):3372-3374. |
[8] | 戴新华,方向,全灿,等. 血清中肌酐的检测方法及其进展[J]. 分析测试学报,2007,26(5):763-767. |
[9] | SAENGER A K,LOCKWOOD C,SNOZEK C L,et al.Catecholamine interference in enzymatic creatinine assays[J]. Clin Chem,2009,55(9):1732-1736. |
[10] | ZINELLU A,CARIA M A,TAVERA C,et al.Plasma creatinine and creatine quantification by capillary electrophoresis diode array detector[J]. Anal Biochem,2005,342(2):186-193. |
[11] | ZINELLU A,SOTGIA S,ZINELLU E,et al.Assay for the simultaneous determination of guanidinoacetic acid,creatinine and creatine in plasma and urine by capillary electrophoresis UV-detection[J]. J Sep Sci,2006,29(5):704-708. |
[12] | STOSCH R,HENRION A,SCHIEL D,et al.Surface-enhanced Raman scattering based approach for quantitative determination of creatinine in human serum[J]. Anal Chem,2005,77(22):7386-7392. |
[13] | YAO H,RAYBURN E R,SHI Q,et al.FDA-approved drugs that interfere with laboratory tests:a systematic search of US drug labels[J]. Crit Rev Clin Lab Sci,2017,54(1):1-17. |
[14] | SYAL K,SRINIVASAN A,BANERJEE D.Streptomycin interference in Jaffe reaction-possible false positive creatinine estimation in excessive dose exposure[J]. Clin Biochem,2013,46(1-2):177-179. |
[15] | 屈跃军. 肾上腺素和利福平对临床生物化学检验的影响[J]. 中国实用医药,2015,10(22):128-129. |
[16] | GUO X,HOU L,CHENG X,et al.Strong negative interference by calcium dobesilate in sarcosine oxidase assays for serum creatinine involving the Trinder reaction[J]. Medicine(Baltimore),2015,94(23):e905. |
[17] | 张军,秦琴,杜大海,等. 多巴胺和多巴酚丁胺对临床部分生化检测项目的干扰[J]. 检验医学,2012,27(3):174-177. |
[18] | PETRIDES A K,NESS M A,JUDGE D P,et al.Fluctuating creatinine in the cardiac unit[J]. Clin Chim Acta,2015,447:52-54. |
[19] | SAENGER A K,LOCKWOOD C,SNOZEK C L,et al.Catecholamine interference in enzymatic creatinine assays[J]. Clin Chem,2009,55(9):1732-1736. |
[20] | 江俊铮,谢梦禹,张卫,等. 维生素C对肌氨酸氧化酶法检测血清肌酐干扰的定量分析[J]. 中华实用诊断与治疗杂志,2012,26(1):64-66. |
[21] | CARLSSON C J,HANSEN H E,HILSTED L,et al.An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments[J]. Scand J Clin Lab Invest,2011,71(5):378-386. |
[22] | RANJITKAR P,GREENE D N.Therapeutic concentrations of hydroxocobalamin interferes with several spectrophotometric assays on the Beckman Coulter DxC and AU680 chemistry analyzers[J]. Clin Chim Acta,2015,450:110-114. |
[23] | 程涌江,李丽,卢卫国,等. 酚磺乙胺对部分生化检验项目干扰的相关研究[J]. 国际检验医学杂志,2011,32(11):1244-1245. |
[24] | GENZEN J R,HUNSAKER J J,NELSON L S,et al.N-acetylcysteine interference of Trinder-based assays[J].Clin Biochem,2016,49(1-2):100-104. |
[25] | 李金密,高飞,陈开春,等. 马来酸罗格列酮造成肌酐苦味酸法检测结果假性增高[J]. 国际检验医学杂志,2012,33(19):2311-2312. |
[26] | BLEL A,ORVEN Y,PALLET N,et al.Pegylated liposomal doxorubicin (Caelyx®)interference with the spectrophotometric Jaffe method for quantitative determination of creatinine in human plasma[J]. Clin Biochem,2017,50(7-8):455-457. |
[27] | 蔡峰,郭一迪,錢婷婷. 常用中药针剂对生化检验结果的影响[J]. 中药药理与临床,2015,31(2):211-212. |
[28] | 叶竟妍,周迎春,朱晔. 复方丹参注射液对部分临床生化项目体外干扰研究[J]. 北华大学学报(自然科学版),2012,13(6):694-696. |
[29] | 冯秀河,朱峰,张强,等. 注射用灯盏花素对临床生化检验项目的干扰研究[J]. 检验医学与临床,2016,13(13):1798-1799. |
[30] | 倪翀,尹元,王伟灵. 常用中成药对检验结果的干扰和预防策略[J]. 检验医学,2017,32(2):149-152. |
[31] | 刘伟,叶永锋. 常用中药针剂对生化检验结果的影响[J]. 内蒙古中医药,2017,36(16):25-26. |
[32] | 尹元,赵延荣,倪翀,等. 红花注射液对8种临床生化检验项目的体外干扰研究[J]. 检验医学,2017,32(10):853-857. |
[1] | WANG Chao, ZHAO Yu. Research progress on formation mechanism and eradication strategy of bacterial persisters [J]. Laboratory Medicine, 2023, 38(8): 790-795. |
[2] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[3] | MA Dongmei, JIANG Dongkui, XIANG Xiaobo, LI Shiliang. Antibacterial activity of 4 Chinese herbal medicines alone and combined with western medicines for extensively drug resistant Acinetobacter baumannii [J]. Laboratory Medicine, 2023, 38(5): 441-445. |
[4] | FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361. |
[5] | WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying. Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing [J]. Laboratory Medicine, 2023, 38(4): 362-367. |
[6] | DENG Jin, LIU Ya, WU Siying, LIAO Quanfeng, ZHANG Weili, XIAO Yuling, XIE Yi, MA Ying, KANG Mei. Antimicrobial drugs combined with drug susceptibility test in vitro [J]. Laboratory Medicine, 2023, 38(4): 385-393. |
[7] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[8] | REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin. Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit [J]. Laboratory Medicine, 2023, 38(2): 157-162. |
[9] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[10] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[11] | RU Haohao, CHEN Lianyong, YANG Xing, CHEN Tao, YAN Shuangqun, XU Lin. Analysis of rifampicin resistance in Mycobacterium tuberculosis determined by Xpert MTB/RIF and phenotypic drug susceptibility test [J]. Laboratory Medicine, 2023, 38(11): 1032-1035. |
[12] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[13] | HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891. |
[14] | XU Qi, PAN Fen, SUN Yan, SHI Yingying, YU Fangyuan, ZHANG Hong. Methodology evaluation of screening techniques for CRE colonized in intestinal tract [J]. Laboratory Medicine, 2022, 37(8): 761-765. |
[15] | WAN Changchun, YANG Hui, ZHUANG Xuewei. Application of polymerase chain reaction melting curve method in determining hypertensive drug-related gene mutations [J]. Laboratory Medicine, 2022, 37(7): 646-651. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||